CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, discuss the controversy surrounding Mylan’s pricing of the EpiPen.

This content was originally posted on CNBC on 8/25/16.